|
601 |
Biliäre Karzinome Enthalten in Onkologische Welt Bd. 14, 2023, Nr. 04: 198-198
|
|
|
602 |
Cholangiokarzinom Enthalten in Onkologische Welt Bd. 14, 2023, Nr. 04: 198-198
|
|
|
603 |
Preoperatively administered single dose of dexketoprofen decreases pain intensity on the first 5 days after craniotomy: A single-centre placebo-controlled, randomized trial Enthalten in Translational Neuroscience Bd. 14, 2023, Nr. 1. 8 S.
|
|
|
604 |
Tackling Congestion in Acute Heart Failure: Is It the Primetime for “Combo Diuretic Therapy?” Enthalten in Cardiorenal Medicine Bd. 13, 2023, Nr. 1: 184-188. 5 S.
|
|
|
605 |
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel kappa opioid receptor agonist ZYKR1: a randomized double-blind placebo-control phase 1 study in healthy adult human participants Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 23.12.2023: 1-9
|
|
|
606 |
Die sechs häufigsten peripheren vestibulären Syndrome Enthalten in Laryngo-Rhino-Otologie 22.12.2023
|
|
|
607 |
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials Enthalten in Thrombosis and haemostasis 21.12.2023
|
|
|
608 |
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials Enthalten in Breast cancer research and treatment 20.12.2023: 1-11
|
|
|
609 |
Brief Report: A Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study of Minocycline in Autism Spectrum Disorder Enthalten in Journal of autism and developmental disorders 15.12.2023: 1-8
|
|
|
610 |
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial Enthalten in Liver cancer Bd. 12, 2023, Nr. 4: 309-320. 12 S.
|
|